You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,857,159


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,857,159 protect, and when does it expire?

Patent 10,857,159 protects LEXETTE and is included in one NDA.

Protection for LEXETTE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fourteen patent family members in thirteen countries.

Summary for Patent: 10,857,159
Title:Halobetasol foam composition and method of use thereof
Abstract: The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol.
Inventor(s): Gauthier; Robert T. (San Diego, CA), Hammer; James D. (Uxbridge, MA)
Assignee: MAYNE PHARMA LLC (Greenville, NC)
Application Number:15/364,966
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis of Patent 10,857,159

Introduction to U.S. Patents and the USPTO

The U.S. Patent and Trademark Office (USPTO) is the federal agency responsible for granting U.S. patents and registering trademarks. Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal practitioners to navigate the complex landscape of intellectual property[1].

The Importance of Patent Scope

Patent scope is a critical aspect of patent quality and has significant implications for innovation and litigation. Debates over patent quality often revolve around the breadth, clarity, and validity of patents. Patents with increased breadth or those that are overly broad can diminish incentives for innovation due to higher licensing and litigation costs[5].

Metrics for Measuring Patent Scope

To quantify patent scope, researchers often use simple yet effective metrics such as independent claim length and independent claim count. These metrics have explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, the breadth of patent classes, and novelty. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process compared to broader claims[5].

Case Study: U.S. Patent 10,857,159

To illustrate the analysis of patent scope and claims, let's consider U.S. Patent 10,857,159. Here is a step-by-step breakdown:

Patent Title and Abstract

  • The title and abstract provide the first glimpse into the invention's nature and scope. For example, if the patent is titled "Method and System for [Specific Technology]," the abstract will outline the key features and innovations.

Independent Claims

  • Independent claims are standalone claims that do not rely on other claims. They define the broadest scope of the invention. Analyzing the length and count of independent claims can provide insights into the patent's breadth and complexity[5].

Dependent Claims

  • Dependent claims build upon independent claims and further limit the scope. They often add specific details or variations to the invention. The number and complexity of dependent claims can indicate the depth and specificity of the patent.

Claim Language

  • The language used in the claims is crucial. Clear and concise language can indicate higher patent quality, while ambiguous or overly broad language may lead to litigation issues. Metrics such as claim length can help quantify this aspect[5].

Prior Art and Citations

  • Understanding the prior art cited in the patent and any forward citations can provide context on the patent's novelty and impact. Databases like PatentsView offer extensive data on citations made to foreign patents and other relevant information[4].

Examination Process

  • The examination process, including the time taken and any amendments made, can reveal how the patent office viewed the claims. Narrower claims at publication are generally associated with a smoother and faster examination process[5].

Maintenance Payments and Litigation

  • The cost of maintaining the patent and any litigation history can indicate the patent's validity and scope. Higher maintenance payments or frequent litigation may suggest broader or more contentious claims.

Legal and Policy Considerations

Small Claims Patent Court

  • The concept of a small claims patent court has been explored to address issues related to patent litigation costs. Studies by the Administrative Conference of the United States (ACUS) have considered the feasibility and structure of such a court, highlighting the need for more accessible and cost-effective dispute resolution mechanisms[2].

Consultative Groups and Stakeholder Input

  • Engaging with a wide range of stakeholders, including academic experts and legal practitioners, is essential for understanding the practical and legal implications of patent scope. Consultative groups have advised on methodologies for quantitative, qualitative, and legal research, ensuring that all perspectives are considered[2].

Data Analysis and Tools

PatentsView Database

  • The PatentsView database offers comprehensive data sets that can be used to analyze various aspects of patents, including citations, inventor data, and location information. This data can be bulk downloaded and analyzed to gain insights into patent trends and scope[4].

Quantitative and Qualitative Research

  • Combining quantitative metrics (like claim length and count) with qualitative research (such as stakeholder interviews) provides a holistic view of patent scope. This approach helps in validating the measures used to assess patent quality[5].

Impact on Innovation and Litigation

Innovation Incentives

  • The scope and clarity of patents directly influence innovation incentives. Clear and narrowly defined patents can encourage innovation by reducing uncertainty and litigation costs. Conversely, overly broad patents can stifle innovation by creating legal barriers[5].

Litigation Costs

  • The breadth and clarity of patent claims significantly affect litigation costs. Patents with ambiguous or overly broad claims are more likely to be involved in costly litigation, which can deter innovation and investment[5].

Best Practices for Patent Drafting

Clear and Concise Language

  • Using clear and concise language in patent claims is essential for avoiding ambiguity and potential litigation. This approach helps in defining the scope of the invention precisely.

Narrow Claims

  • Drafting narrower claims can streamline the examination process and reduce the likelihood of disputes. This strategy aligns with the findings that narrower claims are associated with a higher probability of grant and shorter examination times[5].

Stakeholder Engagement

  • Engaging with stakeholders, including inventors, legal practitioners, and industry experts, can provide valuable insights into the practical implications of patent scope. This engagement ensures that the patent is both legally sound and practically viable.

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are effective metrics for measuring patent scope.
  • Clear Language: Using clear and concise language in claims is crucial for avoiding ambiguity and litigation.
  • Narrow Claims: Narrower claims are associated with a smoother examination process and reduced litigation risks.
  • Stakeholder Input: Engaging with a wide range of stakeholders is essential for understanding the practical and legal implications of patent scope.
  • Data Analysis: Utilizing databases like PatentsView can provide comprehensive insights into patent trends and scope.

FAQs

What is the role of the USPTO in granting patents?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria for patentability.

How do independent claim length and count measure patent scope?

Independent claim length and count are metrics that quantify the breadth and complexity of a patent. Longer and more numerous independent claims generally indicate broader patents.

Why is clear language important in patent claims?

Clear language helps avoid ambiguity and potential litigation by precisely defining the scope of the invention.

What is the potential impact of a small claims patent court?

A small claims patent court could provide a more accessible and cost-effective mechanism for resolving patent disputes, reducing litigation costs and encouraging innovation.

How can data from PatentsView be used in patent analysis?

Data from PatentsView can be used to analyze various aspects of patents, including citations, inventor data, and location information, providing comprehensive insights into patent trends and scope.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,857,159

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma LEXETTE halobetasol propionate AEROSOL, FOAM;TOPICAL 210566-001 May 24, 2018 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,857,159

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016372789 ⤷  Subscribe
Brazil 112018012349 ⤷  Subscribe
Canada 3008753 ⤷  Subscribe
China 108601733 ⤷  Subscribe
Eurasian Patent Organization 035300 ⤷  Subscribe
Eurasian Patent Organization 201891351 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.